HA-1A in gram-negative sepsis.
Jennings
M
M
Department of Medicine and Pharmacology, University of Sheffield, England.
D000911:Antibodies, Monoclonal / Q000191:economics* / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy*; D003362:Cost-Benefit Analysis; D006090:Gram-Negative Bacteria; D006801:Humans